Atelerix Life Sciences Inc. Announces BARDA Contract to Support First-in-Human Clinical Trial of ATLX-0199
New therapeutic treatment being developed to reverse respiratory depression CHARLOTTESVILLE, VA, UNITED STATES, September 27, 2023 /EINPresswire.com/ -- Atelerix Life Sciences Inc., a leader in new therapeutics for unmet medical needs related to …